Aminogram ®
A leading company in the field of body composition for over 30 years.
Our Identity
Stemming from historical expertise in bioimpedance analysis, AMINOGRAM has been committed since its inception to a demanding scientific approach, based on a solid knowledge of body composition analysis techniques and its evolution over time.
Founded in 2003, AMINOGRAM benefits from the experience of its co-founder, a researcher committed to innovation, who developed the first portable bioimpedance device assisted by a “Psion-Siena” type organizer as early as 1996. He then decided, with his daughter Mélody Letourneur, to create AMINOGRAM with the goal of designing body composition analysis devices that are high-performing, reliable, and closely meet the needs of users.
Our goal is clear: to transform advanced measurement technology into a truly useful tool, interpretable and applicable daily by professionals.
AMINOGRAM is a French company: the design, manufacturing, control, and evolution of products are carried out in France. This complete mastery, from design to manufacturing, guarantees reliable devices that comply with the highest medical standards and are adapted to field constraints.
Data quality, tool portability, and their real clinical use are at the heart of our approach. AMINOGRAM devices and solutions are primarily intended for health, nutrition, and research professionals.
Our vision
Innovation, based on science, common sense, and ergonomics
Relying on science
Mastering all scientific works and data published since 1962 on body composition analysis by bioimpedance, stemming from research conducted by eminent electrophysiologists. Integrating this scientific expertise into the design and evolution of our devices.
Exercising common sense
Selecting, at each design stage, the solutions that appear to be the most efficient in view of available technologies. Evolving our devices based on research progress and the possibilities offered by innovation.
Placing ergonomics at the heart of usage
Facilitating the use of devices and making body composition analysis by bioimpedance a reliable diagnostic aid reference, fully integrated into professional clinical and field practices.
Making body composition analysis by bioimpedance a reliable scientific reference, sustainably integrated into professional clinical and field practices.
Our mission
Putting science, data reliability, and useful innovation at the service of professionals by developing body composition analysis solutions designed for concrete, interpretable, and sustainable use.
Ensuring the continuous evolution of our result interpretation software by integrating new validated scientific data and available methodological advances.
Exchanging with leading professionals in the field and relying on user field feedback to anticipate needs, improve devices, and adapt solutions to real-world uses.
Our history
Since its creation, AMINOGRAM has been part of a continuous scientific approach dedicated to body composition analysis by bioimpedance, developing reliable, innovative solutions designed for professional use.
- 2003
- 2005
- 2006
- 2007
- 2014
- 2017
- 2018
- 2020
- 2024
Creation of AMINOGRAM with the ambition to develop innovative body composition analysis solutions by bioimpedance.
2003
Launch of BIO ZM, the first multi-frequency and multi-algorithm device associated with expert interpretation software.
2005
Development of the first nutrition software integrated with bioimpedance.
2006
Launch of BIO ZM II, the first device integrating Bluetooth technology.
2007
Presentation of the BIODY XPERTZM, Major breakthrough in ergonomics and portability: first direct foot/hand measurement device. Patented wireless system, marking a major breakthrough in ergonomics and portability. Praised by BFM TV as a French innovation present at CES Las Vegas, 2015 Award of Excellence granted by CIUS Santé de Nice.
2014
Launch of BIODY COACHZM, the first device fully connected to the cloud.
2017
Evolution of BIODY XPERTZM II, a cloud-connected medical device.
2018
2020
- Ergonomics: first device with dual function: possibility of direct measurement without cables or with cables (for optimized measurement in a lying position for people with reduced mobility).
- New function allowing access to Impedance Spectroscopy, combining traditional bioimpedance (BIA) and impedance spectroscopy (BIS) for advanced body composition and tissue analysis.
- Publications on evaluations conducted from 2023 to 2025.
2024
Our values
Scientific rigor
Science is at the heart of every AMINOGRAM development. Our solutions are based on solid scientific foundations, proven methodologies, and reliable data, serving demanding professional practices.
Data reliability and quality
AMINOGRAM is committed to providing accurate, reproducible, and interpretable results. Data reliability is essential to enable relevant monitoring and confident use.
Field utility and practicality
Our solutions are designed to be simple to use, portable, and adapted to everyday realities. Innovation only makes sense if it facilitates practice and integrates naturally into care pathways.
Proximity to professionals
We develop our solutions in close collaboration with users. Listening, supporting, and understanding field needs are at the heart of our approach.
Commitment and French manufacturing
An independent French company, AMINOGRAM values mastered expertise, manufacturing in France, and a responsible approach, guaranteeing quality, traceability, and sustainability.
AMINOGRAM International
AMINOGRAM deploys its body composition analysis solutions internationally, in collaboration with a network of specialized distributors and partners.
We regularly study new partnerships to support the dissemination of reliable, scientific solutions adapted to professional uses.
Would you like to distribute AMINOGRAM in your country? Contact us
Quality & Regulatory Compliance
Since its creation, AMINOGRAM has developed its devices according to high standards of quality, safety, and reliability.
Design, manufacturing, and control activities are part of a quality management system compliant with Regulation (EU) 2017/745 (MDR), covering the entire life cycle of the devices.
The BIODY XPERTZM3 is a Class IIa medical device, compliant with European regulations. Its compliance is evidenced by an EU quality assurance certificate for production issued by the notified body GMED (No. 0459).
AMINOGRAM is ISO 13485:2016 certified, attesting to the compliance of its quality management system for the manufacturing and marketing of medical devices.
Health data is hosted in France with an HDS-certified host, in accordance with current regulatory requirements.